Remove 2023 Remove Assay Development Remove DNA Remove Pharma Companies
article thumbnail

AI At The Frontier: Empowering Early Career Professionals In Drug Discovery

Elrig

Srinivasan has led the development of multiple computational pipelines to process data from different next generation sequencing techniques with applications in oncology, genome editing systems including CRISPR-Cas mediated DNA editing, and ADAR-mediated RNA editing. big pharma or startups/spin off? What pro/cons?